Magnetic Resonance Image Guided Radiotherapy (MRIgRT) course

Key information

Next course dates

22-23 September 2025, closing date for registrations 18th August 2025

Location

BLB Sutton, SM2 5PT
See Sutton map at the bottom of our contacts page.

This course is organised by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Course outline

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading practitioners in the field, develop skills and share knowledge with other professionals involved in MRI in radiotherapy.

This two day course aims to improve understanding of MRIgRT, focusing on the knowledge and skills required to support current and future needs in radiotherapy.

The development of MRI in radiotherapy planning involves close communication with radiology and radiotherapy professionals. This course is aimed at all professionals involved in or interested in MRI for radiotherapy, including radiographers, physicists and clinicians.

Course Organisers: Professor Helen McNair, Ms Erica Scurr, Dr Shaista Hafeez, Miss Trina Herbert, and Professor Uwe Oelfke

"Great overall knowledge for all professions interested in MRI - extremely informative."
– Therapeutic Radiographer and course attendee

Course overview

The course will include taught and practical workshops to:

Improve understanding of the basic principles of MRI
Build foundation skills to support the increase in demand for MRI simulation
Develop practical skills
Learn about current clinical pathways and the latest research developments

The practical demonstrations will include:

MR simulation, image acquisition and interpretation, RT set up and safety.
Sequence and parameter manipulation
Adaptive workflow on the MR Linac

Provisional lecture list

The clinical need for MR in radiotherapy
Image contrast, Resolution and Factors affecting signal-to-noise
MR Simulation
MR planning workflow
MR-CT fusion planning
Image fusion and dosimetry
Safety considerations
Regional MR in RT – Pelvis,
Regional MR in RT, Abdomen (liver and pancreas)
Regional MR in RT, Breast
Managing motion (4D)
MR in Brachytherapy
MR Linac QA
Diffusion Weighted Imaging (DWI) principles and applications
Functional imaging

Programme draft

Previous comments from attendees

“I have now significantly more knowledge of potential for MRI in radiotherapy, its benefits and drawbacks.” – Clinical Oncologist

“MRI in radiotherapy planning is a lot more complicated than I thought. Highlighted that we would be crazy to do more MRI without an MRI physicist in the trust.” – Radiotherapy Physicist

“Excellent overview of MRI and how it is and will be used in the future.” – Radiotherapy Physicist

“Collaboration between diagnostic and Therapy radiographers is vital in MR planning.” – Therapeutic Radiographer

Accommodation

Accommodation is available in local hotels, details can be supplied upon request.

Further information

For further details on up to date course content call +44 (0)20 8661 3704 or email Cheryl Taylor.

Latest ICR News

Microscope image of an ovarian clear cell carcinoma

ICR welcomes approval for new ovarian cancer drug combination

09/05/25

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA).

See full story

New weakness to target breast cancer cells discovered

07/05/25

Researchers at The Institute of Cancer Research, London, have uncovered a hidden weakness in some breast cancer tumours that could lead to smarter treatment decisions.

See full story

New protective role of gene frequently mutated in cancer uncovers potential therapeutic target

02/05/25

New research into how cancer develops has uncovered more detail about the importance of the centromere, a region of human DNA that has a critical role in effective cell division.

See full story

Intermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour

Smarter chemotherapy approach could delay drug resistance in ovarian cancer

01/05/25

Adaptive chemotherapy – a personalised approach to giving chemotherapy – can prolong survival in lab models of ovarian cancer, according to new results published in the journal Cancer Research.

See full story